Navigation Links
D'Oliveira & Associates Now Offers a No Win No Fee Promise in Zithromax Cases
Date:1/25/2013

(PRWEB) January 25, 2013

The Personal Injury Lawyers at d'Oliveira & Associates are currently seeking clients who have had heart problem, cardiovascular injury, or even death while taking the anti-infection drug Zithromax. The firm is working with some of the leading Zithromax lawyers in the country and are offering a "no win, no fee promise" to these individuals and families, which means that there will be no fee charged unless and until the client receives a settlement or an award.

The U.S. Food and Drug Administration has issued a warning to all healthcare professionals about the increased risk of cardiovascular death for persons with pre-existing heart problems who are taking Zithromax. The FDA has responded to a 2012 study published in the New England Journal of Medicine that found an increased risk of death for those patients taking "Azithromycin," or Zithromax, over the course of 5-days. Similarly, the persons in the same study that were either not taking Zithromax or taking some other form of amoxicillin were under no such increased risk of cardiovascular death.

Zithromax belongs to a group of drugs known as "macrolide antibiotics" that are used in for the treatment of different types of infections such as ear and eye infections, bronchitis, pneumonia, strep throat, typhoid, and sinusitis. Marketed by Pzifer Inc., Zithromax is a commonly prescribed drug with sales of $464 million for 2011 in the United States alone.

The report published in the New England Journal of Medicine represented a 14-year study which showed that Zithromax users were nearly three times as likely to suffer a cardiovascular death than those taking either no drugs or another form of antibiotic. While Pfizer indicated that it would examine the study, the FDA issued an alert to doctors regarding the increased risk which suggested doctors to review its clients with underlying heart prob
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. d'Oliveira & Associates Helps Fall River, MA Teenager Receive $38,500 in Auto Accident Settlement
2. d'Oliveira & Associates Notes the Announcement of Zoloft Birth Defects Multidistrict Litigation (MDL) Set to Start in Mid-September 2014
3. The Law Firm of d'Oliveira and Associates Now Offers a No Win - No Free Promise in Nexium Cases
4. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
5. d'Oliveira & Associates Helps Newport Woman Receive $150,000 Settlement for Auto Accident; Case: MI-11889
6. d'Oliveira & Associates Helps Rhode Island Estate Receive the Maximum Compensation Under RI Law of $250,000 Settlement for Fatal Auto Accident
7. d'Oliveira & Associates Helps Westport, MA Man Receive $100,000 Settlement for Reckless Driving Accident
8. d'Oliveira & Associates Help New Bedford Woman Receive $95,000 in Damages for Dog Bite Injury Case #:NB-11736
9. E-Prescribing Market is Growing at a CAGR of 26% & to Reach Worth $794 Million by 2017 - New Report by MarketsandMarkets
10. Apheresis Market is Growing at a CAGR of 11.0% & to Reach $1.9 Billion By 2017 - by MarketsandMarkets
11. Cervical Health Awareness Month 2013: Maternal & Family Health Services Focuses on Access to Reproductive Healthcare to Reduce Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Evolve Medical Clinics, the first ... urgent care arena, is having its Grand Opening ... health fair the clinic is sponsoring. Evolve offers ... patients in achieving high quality, convenient medical care. ... is a groundbreaking change in healthcare. The membership ...
(Date:9/2/2014)... September 02, 2014 Last year, SIGVARIS ... with the launch of a luxurious line of graduated compression ... the SEA ISLAND COTTON Socks are joining the SIGVARIS MEDICAL ... more people the comfort of natural cotton fibers. , ... are surprised to find socks as soft as the finest ...
(Date:9/2/2014)... Ticket Down is a reputable source ... September will be an exciting week for soccer fans in ... Ecuador and Bolivia will battle on U.S. soil in friendly ... September 5th - September 9th: , Brazil vs. Ecuador ... Mexico vs. Chile Tickets at Levi's Stadium on ...
(Date:9/2/2014)... 02, 2014 The exclusive ClinicCRM patient ... designed to help doctors manage foreign patient flow, enable ... conversion rates and clink revenue. Since its launch in ... in sales revenue and a 70 percent increase in ... their own healthcare practices. , With its ease of ...
(Date:9/2/2014)... but your outpatient doctor does not know? Or ... care, but your doctor does not have the ... or incomplete communication from hospitals to outpatient primary ... and lead to hospital readmissions. , However, ... improve hospitals, communication during patient care transitions. Researchers ...
Breaking Medicine News(10 mins):Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 2Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 4Health News:Can data motivate hospital leaders to improve care transitions? 2
... implications of the Clinical Antipsychotic Trials of Intervention ... antipsychotic medication perphenazine// was less expensive and no ... used in the trial during initial treatment, suggesting ... treating schizophrenia. The study, published in the American ...
... has shown that a new compound may improve the fertility ... percentage sperm motility. ,The sperm from male smokers ... there was a doubling in the fertilizing capacity of sperm ... Ph.D., and colleagues presented the findings at the 2006 meeting ...
... The world has heard of the illustrious mathematician and physicist, ... of Relativity’. But did you know that Albert Einstein suffered ... three years old? Einstein also had a problem with Maths ... a world famous Mathematician, it is undoubtedly, the will to ...
... intensive care doctors are responsible for large cost variations ... the intensive care unit (ICU), higher resource// use has ... mortality. ,This research appears in the first ... Respiratory and Critical Care Medicine, published by the American ...
... once treated mainly elderly patients for health problems such ... younger patients who have the same ailments. ... Proceedings focuses on the increasing prevalence of metabolic syndrome, ... obesity, high blood pressure and abnormal levels of glucose ...
... fallen drastically, and the rate of decline has improved considerably ... of data// from the National Long-Term Care Survey (NLTCS). The ... of Sciences, has revealed that the severe disability among the ... 1982 to 19 percent in 2004/2005. ,The study ...
Cached Medicine News:Health News:Older Medication May Be More Cost-Effective for Some Schizophrenia Patients 2Health News:New Compound May Improve Fertility in Smokers 2Health News:New Compound May Improve Fertility in Smokers 3Health News:Equal Opportunity for the Disabled 2Health News:Large Variations in Cost Has No Effect on Length of Stay or Mortality 2Health News:Large Variations in Cost Has No Effect on Length of Stay or Mortality 3Health News:Treating Obesity Vital for Public Health, Physicians Say 2Health News:Disability Factor Among Older Americans Shows Improvement 2
(Date:9/2/2014)... Astellas has appointed James Kellerman ... the Americas. Kellerman will report directly to Linda ... Astellas. In his new role, Kellerman will lead a ... and manage the region,s intellectual property matters, coordinating closely ... very pleased to welcome Jim to Astellas. Jim brings ...
(Date:9/2/2014)... Sept. 2, 2014  Numotion is pleased to announce the ... of Directors. Mark is a 30-year retired ... positions across the organization and was a GE Company Officer ... Mark spent many years running business units within GE Healthcare, ... Healthcare Americas. "We are delighted to welcome ...
(Date:9/2/2014)... , Sept. 2, 2014  On July 31, ... to Congress that it is moving forward to regulate ... the minutes until laboratories throughout the U.S. will need ... Although some medical laboratories may subscribe to the ... FDA to put guidelines in place, it,s widely acknowledged ...
Breaking Medicine Technology:Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3
... Solutions Development Company (MSDC), a drug discovery and ... metabolic diseases, announced today that it has launched ... second drug candidate for the treatment of type ... placebo-controlled clinical trial will involve approximately 125 patients ...
... SAN and NYSE: SNY ) announced today ... Rights (CVRs) offered to Genzyme shareholders as part of ... by the U.S. Securities and Exchange Commission. ... Genzyme, sanofi-aventis has commenced an exchange offer to acquire ...
Cached Medicine Technology:Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes 2Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective 2Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective 3
The Vitatron Pirouet S+ lead series are endocardial leads with extendable/retractable helical screw designed for reliable fixation and optimal pacing characteristics....
Used with permanent pacing leads....
Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
... the Tupos LV/A+, the single-lead principle has been ... time. The complete system, which consists of the ... minimizes the scope of surgery and the risk ... atrium and the ventricle via a single lead. ...
Medicine Products: